205 related articles for article (PubMed ID: 15026063)
21. Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase.
Melamed JY; Egbertson MS; Varga S; Vacca JP; Moyer G; Gabryelski L; Felock PJ; Stillmock KA; Witmer MV; Schleif W; Hazuda DJ; Leonard Y; Jin L; Ellis JD; Young SD
Bioorg Med Chem Lett; 2008 Oct; 18(19):5307-10. PubMed ID: 18774711
[TBL] [Abstract][Full Text] [Related]
22. Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors.
Dayam R; Sanchez T; Clement O; Shoemaker R; Sei S; Neamati N
J Med Chem; 2005 Jan; 48(1):111-20. PubMed ID: 15634005
[TBL] [Abstract][Full Text] [Related]
23. Chicoric acid analogues as HIV-1 integrase inhibitors.
Lin Z; Neamati N; Zhao H; Kiryu Y; Turpin JA; Aberham C; Strebel K; Kohn K; Witvrouw M; Pannecouque C; Debyser Z; De Clercq E; Rice WG; Pommier Y; Burke TR
J Med Chem; 1999 Apr; 42(8):1401-14. PubMed ID: 10212126
[TBL] [Abstract][Full Text] [Related]
24. Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors.
Plewe MB; Butler SL; Dress KR; Hu Q; Johnson TW; Kuehler JE; Kuki A; Lam H; Liu W; Nowlin D; Peng Q; Rahavendran SV; Tanis SP; Tran KT; Wang H; Yang A; Zhang J
J Med Chem; 2009 Nov; 52(22):7211-9. PubMed ID: 19873974
[TBL] [Abstract][Full Text] [Related]
25. Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes.
Grobler JA; Stillmock K; Hu B; Witmer M; Felock P; Espeseth AS; Wolfe A; Egbertson M; Bourgeois M; Melamed J; Wai JS; Young S; Vacca J; Hazuda DJ
Proc Natl Acad Sci U S A; 2002 May; 99(10):6661-6. PubMed ID: 11997448
[TBL] [Abstract][Full Text] [Related]
26. Dihydroxypyridopyrazine-1,6-dione HIV-1 integrase inhibitors.
Wai JS; Kim B; Fisher TE; Zhuang L; Embrey MW; Williams PD; Staas DD; Culberson C; Lyle TA; Vacca JP; Hazuda DJ; Felock PJ; Schleif WA; Gabryelski LJ; Jin L; Chen IW; Ellis JD; Mallai R; Young SD
Bioorg Med Chem Lett; 2007 Oct; 17(20):5595-9. PubMed ID: 17822898
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of HQCAs with aryl or benzyl substituents on N-1 position as potential HIV-1 integrase inhibitors.
He QQ; Zhang X; Wu HQ; Gu SX; Ma XD; Yang LM; Zheng YT; Chen FE
Bioorg Med Chem; 2011 Sep; 19(18):5553-8. PubMed ID: 21862337
[TBL] [Abstract][Full Text] [Related]
28. A series of 5-(5,6)-dihydrouracil substituted 8-hydroxy-[1,6]naphthyridine-7-carboxylic acid 4-fluorobenzylamide inhibitors of HIV-1 integrase and viral replication in cells.
Embrey MW; Wai JS; Funk TW; Homnick CF; Perlow DS; Young SD; Vacca JP; Hazuda DJ; Felock PJ; Stillmock KA; Witmer MV; Moyer G; Schleif WA; Gabryelski LJ; Jin L; Chen IW; Ellis JD; Wong BK; Lin JH; Leonard YM; Tsou NN; Zhuang L
Bioorg Med Chem Lett; 2005 Oct; 15(20):4550-4. PubMed ID: 16102965
[TBL] [Abstract][Full Text] [Related]
29. [Advances in the study of HIV-1 integrase inhibitor of aryl beta-diketoacids].
Wang C; Zhao GS
Yao Xue Xue Bao; 2006 Sep; 41(9):801-7. PubMed ID: 17111823
[No Abstract] [Full Text] [Related]
30. Design and synthesis of 8-hydroxy-[1,6]naphthyridines as novel inhibitors of HIV-1 integrase in vitro and in infected cells.
Zhuang L; Wai JS; Embrey MW; Fisher TE; Egbertson MS; Payne LS; Guare JP; Vacca JP; Hazuda DJ; Felock PJ; Wolfe AL; Stillmock KA; Witmer MV; Moyer G; Schleif WA; Gabryelski LJ; Leonard YM; Lynch JJ; Michelson SR; Young SD
J Med Chem; 2003 Feb; 46(4):453-6. PubMed ID: 12570367
[TBL] [Abstract][Full Text] [Related]
31. Triketoacid inhibitors of HIV-integrase: a new chemotype useful for probing the integrase pharmacophore.
Walker MA; Johnson T; Ma Z; Banville J; Remillard R; Kim O; Zhang Y; Staab A; Wong H; Torri A; Samanta H; Lin Z; Deminie C; Terry B; Krystal M; Meanwell N
Bioorg Med Chem Lett; 2006 Jun; 16(11):2920-4. PubMed ID: 16546383
[TBL] [Abstract][Full Text] [Related]
32. The use of a new in vitro reaction substrate reproducing both U3 and U5 regions of the HIV-1 3'-ends increases the correlation between the in vitro and in vivo effects of the HIV-1 integrase inhibitors.
Tramontano E; Onidi L; Esposito F; Badas R; La Colla P
Biochem Pharmacol; 2004 May; 67(9):1751-61. PubMed ID: 15081874
[TBL] [Abstract][Full Text] [Related]
33. De novo design and synthesis of HIV-1 integrase inhibitors.
Makhija MT; Kasliwal RT; Kulkarni VM; Neamati N
Bioorg Med Chem; 2004 May; 12(9):2317-33. PubMed ID: 15080929
[TBL] [Abstract][Full Text] [Related]
34. A platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors.
Kawasuji T; Fuji M; Yoshinaga T; Sato A; Fujiwara T; Kiyama R
Bioorg Med Chem; 2006 Dec; 14(24):8420-9. PubMed ID: 17005407
[TBL] [Abstract][Full Text] [Related]
35. Discovery and synthesis of HIV integrase inhibitors: development of potent and orally bioavailable N-methyl pyrimidones.
Gardelli C; Nizi E; Muraglia E; Crescenzi B; Ferrara M; Orvieto F; Pace P; Pescatore G; Poma M; Ferreira Mdel R; Scarpelli R; Homnick CF; Ikemoto N; Alfieri A; Verdirame M; Bonelli F; Paz OG; Taliani M; Monteagudo E; Pesci S; Laufer R; Felock P; Stillmock KA; Hazuda D; Rowley M; Summa V
J Med Chem; 2007 Oct; 50(20):4953-75. PubMed ID: 17824681
[TBL] [Abstract][Full Text] [Related]
36. Discovery and analysis of inhibitors of the human immunodeficiency integrase.
Hazuda D; Felock PJ; Hastings JC; Pramanik B; Wolfe AL
Drug Des Discov; 1997 May; 15(1):17-24. PubMed ID: 9332828
[TBL] [Abstract][Full Text] [Related]
37. Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors.
Czyz A; Stillmock KA; Hazuda DJ; Reznikoff WS
Biochemistry; 2007 Sep; 46(38):10776-89. PubMed ID: 17725323
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and biological evaluation of chicoric acid analogs as inhibitors of HIV-1 integrase.
Charvat TT; Lee DJ; Robinson WE; Chamberlin AR
Bioorg Med Chem; 2006 Jul; 14(13):4552-67. PubMed ID: 16524737
[TBL] [Abstract][Full Text] [Related]
39. Structure activity of 3-aryl-1,3-diketo-containing compounds as HIV-1 integrase inhibitors.
Pais GC; Zhang X; Marchand C; Neamati N; Cowansage K; Svarovskaia ES; Pathak VK; Tang Y; Nicklaus M; Pommier Y; Burke TR
J Med Chem; 2002 Jul; 45(15):3184-94. PubMed ID: 12109903
[TBL] [Abstract][Full Text] [Related]
40. Parallel one-pot synthesis and structure-activity relationship study of symmetric formimidoester disulfides as a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
Cesarini S; Spallarossa A; Ranise A; Schenone S; Bruno O; La Colla P; Casula L; Collu G; Sanna G; Loddo R
Bioorg Med Chem; 2008 Jun; 16(12):6353-63. PubMed ID: 18502646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
